MA23611A1 - Procede pour la synthese de sulfoxydes substitues - Google Patents

Procede pour la synthese de sulfoxydes substitues

Info

Publication number
MA23611A1
MA23611A1 MA23950A MA23950A MA23611A1 MA 23611 A1 MA23611 A1 MA 23611A1 MA 23950 A MA23950 A MA 23950A MA 23950 A MA23950 A MA 23950A MA 23611 A1 MA23611 A1 MA 23611A1
Authority
MA
Morocco
Prior art keywords
synthesis
substituted sulfoxides
sulfoxides
substituted
Prior art date
Application number
MA23950A
Other languages
English (en)
Inventor
Urban Jan Stenhede
Erick Magnus Larsson
Unge Peroskar Sverker Von
Hanna Kristina Cotton
Henrick Sorensen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20394753&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA23611(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of MA23611A1 publication Critical patent/MA23611A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA23950A 1994-07-15 1995-07-10 Procede pour la synthese de sulfoxydes substitues MA23611A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402510A SE504459C2 (sv) 1994-07-15 1994-07-15 Förfarande för framställning av substituerade sulfoxider

Publications (1)

Publication Number Publication Date
MA23611A1 true MA23611A1 (fr) 1996-04-01

Family

ID=20394753

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23950A MA23611A1 (fr) 1994-07-15 1995-07-10 Procede pour la synthese de sulfoxydes substitues

Country Status (41)

Country Link
US (1) US5948789A (fr)
EP (1) EP0773940B2 (fr)
JP (1) JP3795917B2 (fr)
KR (1) KR100356252B1 (fr)
CN (1) CN1070489C (fr)
AR (1) AR003443A1 (fr)
AT (1) ATE242233T1 (fr)
AU (1) AU688074B2 (fr)
BR (1) BR9508292A (fr)
CA (1) CA2193994C (fr)
CZ (1) CZ297987B6 (fr)
DE (1) DE69530987T3 (fr)
DK (1) DK0773940T4 (fr)
DZ (1) DZ1911A1 (fr)
EE (1) EE03354B1 (fr)
EG (1) EG24534A (fr)
ES (1) ES2199998T5 (fr)
FI (2) FI117672B (fr)
HR (1) HRP950401B1 (fr)
HU (1) HU226361B1 (fr)
IL (1) IL114477A (fr)
IS (1) IS1772B (fr)
MA (1) MA23611A1 (fr)
MX (1) MX9700358A (fr)
MY (1) MY113180A (fr)
NO (1) NO312101B1 (fr)
NZ (1) NZ289959A (fr)
PL (1) PL186342B1 (fr)
PT (1) PT773940E (fr)
RU (1) RU2157806C2 (fr)
SA (1) SA95160294B1 (fr)
SE (1) SE504459C2 (fr)
SI (1) SI0773940T2 (fr)
SK (1) SK284059B6 (fr)
TN (1) TNSN95081A1 (fr)
TR (1) TR199500861A2 (fr)
TW (1) TW372971B (fr)
UA (1) UA47409C2 (fr)
WO (1) WO1996002535A1 (fr)
YU (1) YU49475B (fr)
ZA (1) ZA955724B (fr)

Families Citing this family (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6747155B2 (en) 1997-05-30 2004-06-08 Astrazeneca Ab Process
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
PL337888A1 (en) 1997-07-03 2000-09-11 Du Pont Pharm Co Imidazoprimidines and imidazopyridines for use in treating neurological disorders
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704183D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New process
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
WO1999038513A1 (fr) * 1998-01-30 1999-08-05 Sepracor Inc. Compositions et procedes d'utilisation du r-lansoprazole
CA2330324A1 (fr) * 1998-04-30 1999-11-04 Sepracor Inc. Compositions a base de s-rabeprazole et procedes
AU3870599A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. R-rabeprazole compositions and methods
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
CN1087739C (zh) * 1998-12-28 2002-07-17 中国科学院成都有机化学研究所 光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
ATE298334T1 (de) 1999-06-30 2005-07-15 Takeda Pharmaceutical Kristalle von lansoprazole
AU6727700A (en) * 1999-08-25 2001-03-19 Takeda Chemical Industries Ltd. Process for the preparation of optically active sulfoxide derivatives
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
WO2001083473A1 (fr) * 2000-04-28 2001-11-08 Takeda Chemical Industries, Ltd. Procede de production d'un derive de sulfoxide optiquement actif
KR100869677B1 (ko) 2000-05-15 2008-11-21 다케다 야쿠힌 고교 가부시키가이샤 결정의 제조방법
DE60131649T2 (de) 2000-05-15 2008-10-30 Takeda Pharmaceutical Co. Ltd. Verfahren zur herstellung eines kristalls
JP5412023B2 (ja) * 2000-08-04 2014-02-12 武田薬品工業株式会社 ベンズイミダゾール化合物の塩およびその用途
KR20100002278A (ko) * 2000-12-01 2010-01-06 다케다 야쿠힌 고교 가부시키가이샤 (ｒ)- 또는 (ｓ)-란소프라졸의 결정
WO2002083608A2 (fr) * 2001-04-13 2002-10-24 Apsinterm Llc Procedes de preparation de sulfinamides et de sulfoxydes
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
WO2003063840A2 (fr) * 2002-01-25 2003-08-07 Santarus, Inc. Administration par voie muqueuse d'inhibiteurs de la pompe a protons
ES2286408T3 (es) 2002-03-05 2007-12-01 Astrazeneca Ab Sales de alquilamonio de omeprazol e esomeprazol.
WO2003089408A2 (fr) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Pyridinylmethyl-sulphinyl-benzimidazole substitue optiquement actif et sels
US7169793B2 (en) 2002-06-27 2007-01-30 Dr. Reddy's Laboratories Limited Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2004035052A1 (fr) 2002-10-16 2004-04-29 Takeda Pharmaceutical Company Limited Preparations solides stables
EA200500673A1 (ru) 2002-10-22 2005-12-29 Рэнбакси Лабораториз Лимитед Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
DE10254167A1 (de) 2002-11-20 2004-06-09 Icon Genetics Ag Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
CN100500660C (zh) * 2002-12-06 2009-06-17 尼可姆公司 用于制备泮托拉唑(pantoprazole)的方法
AR042277A1 (es) * 2002-12-06 2005-06-15 Altana Pharma Ag Un procedimiento para la preparacion de sulfinil benzimidazoles opticamente puros
ES2383679T3 (es) * 2002-12-06 2012-06-25 Nycomed Gmbh Procedimiento para la preparación de (S)-pantoprazol
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
AR046245A1 (es) * 2002-12-16 2005-11-30 Ranbaxy Lab Ltd Sales de calcio de rabeprazol
CA2510849A1 (fr) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Etats solides de sodium de pantoprazole, leurs procedes de preparation et procedes de preparation d'hydrates de sodium de pantoprazole connus
US20060094762A1 (en) * 2003-01-07 2006-05-04 Yatendra Kumar Magnesium salt of imidazole derivative
WO2004073654A2 (fr) * 2003-02-20 2004-09-02 Santarus, Inc. Liberation immediate d'un complexe antacide d'omeprazole presentant une nouvelle formulation pour une elimination rapide et prolongee d'acide gastrique
US20060247277A1 (en) * 2003-02-28 2006-11-02 Yatendra Kumar Polymorphs of s-omeprazole
CA2518999A1 (fr) * 2003-03-12 2004-09-23 Teva Pharmaceutical Industries Ltd Formes solides cristallines et amorphes de pantoprazole et procedes de preparation de ces formes
JP4355703B2 (ja) * 2003-03-13 2009-11-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 歯ぎしりの予防剤または治療剤
CA2520157A1 (fr) * 2003-03-28 2004-10-14 Sidem Pharma Procede de preparation enantioselective de derives de sulfoxydes
FR2852956B1 (fr) * 2003-03-28 2006-08-04 Negma Gild Procede de preparation enantioselective de derives de sulfoxydes
CN1842525A (zh) * 2003-05-05 2006-10-04 兰贝克赛实验室有限公司 苯并咪唑衍生物的钡盐
WO2004111029A2 (fr) 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Procede de preparation de benzimidazoles 2-[(pyridinyl)methyl]sulfinyle substitues et nouveau derives chlorures de pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302382D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
WO2005054228A1 (fr) * 2003-12-05 2005-06-16 Hetero Drugs Limited Procede de preparation d'enantiomeres de pyridinylmethylsulfinyl- benzamide substitues
SE0400410D0 (sv) * 2004-02-20 2004-02-20 Astrazeneca Ab New compounds
EP1740571B1 (fr) 2004-04-28 2009-07-29 Hetero Drugs Limited Methode servant a preparer des composes de pyridinylmethyl-1h-benzimidazole sous forme d'enantiomeres simples ou enrichis
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE602004025386D1 (de) * 2004-05-28 2010-03-18 Hetero Drugs Ltd Neue stereoselektive synthese von benzimidazolsulfoxiden
CA2568652A1 (fr) * 2004-06-02 2005-12-15 Altana Pharma Ag Procede permettant la preparation de composes pyridin-2-yl-methyl-sulfinyl-1h-benzimidazol
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
WO2006001753A1 (fr) 2004-06-24 2006-01-05 Astrazeneca Ab Nouveau procede de preparation de modifications de cristal a utiliser dans la preparation de sel de sodium d'esomeprazole
WO2006001755A1 (fr) * 2004-06-24 2006-01-05 Astrazeneca Ab Nouvelle forme modifiee de cristaux de sels d'esomeprazole sodium
FR2876101B1 (fr) * 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
PL1802584T3 (pl) * 2004-10-11 2010-03-31 Ranbaxy Laboratories Ltd Sposób wytwarzania podstawionych sulfotlenków
US7592111B2 (en) * 2004-11-05 2009-09-22 Xerox Corporation Imaging member
US20060217423A1 (en) 2005-03-25 2006-09-28 Jingen Deng Substituted sulfoxide compounds, methods for preparing the same and use thereof
CN101098867B (zh) * 2005-03-25 2010-08-11 丽珠医药集团股份有限公司 取代的亚砜类化合物和其制备方法及用途
RU2007145207A (ru) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
WO2006131338A2 (fr) * 2005-06-08 2006-12-14 Lek Pharmaceuticals D.D. Solvate cristallin de sodium d'omeprazole
US20070043085A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of amorphous form of neutral esomeprazole
KR20080076924A (ko) * 2005-12-05 2008-08-20 아스트라제네카 아베 에소메프라졸 비-염 형태의 제조를 위한 신규 방법
EP1801110A1 (fr) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Sel d'arginine d'ésoméprazole
DE102005061720B3 (de) * 2005-12-22 2006-10-19 Ratiopharm Gmbh Enantioselektive Herstellung von Benzimidazolderivaten und ihren Salzen
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
KR101289215B1 (ko) 2005-12-28 2013-07-29 유니온 퀴미코 파르마세우티카, 에스.에이. 오메프라졸의 (에스)-엔안티오머의 제조 방법
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
US8063074B2 (en) * 2006-05-04 2011-11-22 Dr. Reddy's Laboratories Limited Polymorphic forms of esomeprazole sodium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
MX2008016196A (es) 2006-07-05 2009-01-20 Lupin Ltd Proceso para la preparacion de enantiomeros opticamente puros u opticamente enriquecidos de compuestos de sulfoxido.
WO2008018091A1 (fr) * 2006-08-08 2008-02-14 Jubilant Organosys Limited Procédé de production de composés de sulfoxyde
JP2009196894A (ja) * 2006-10-13 2009-09-03 Eisai R & D Management Co Ltd スルフィニルベンズイミダゾール化合物またはその塩の製造方法
WO2008047681A1 (fr) 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
EP1947099A1 (fr) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Procédé pour l'élimination de solvant des sels d'oméprazole
JP2010519284A (ja) 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法
RU2341524C1 (ru) * 2007-05-02 2008-12-20 Новосибирский институт органической химии им. Н.Н. Ворожцова СО РАН (НИОХ СО РАН) СПОСОБ ПОЛУЧЕНИЯ ОПТИЧЕСКИ АКТИВНОГО 5-МЕТОКСИ-2-((4-МЕТОКСИ-3,5-ДИМЕТИЛПИРИДИН-2-ИЛ)МЕТИЛСУЛЬФИНИЛ)-1Н-БЕНЗО[d]ИМИДАЗОЛА
US8492551B2 (en) * 2007-06-07 2013-07-23 Aurobindo Pharma. Ltd. Process for preparing an optically active proton pump inhibitor
CN101323609B (zh) * 2007-06-15 2013-05-01 成都福瑞生物工程有限公司 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
WO2009066321A2 (fr) * 2007-10-03 2009-05-28 Ipca Laboratories Limited Procédé pour composés de sulfoxyde optiquement actifs
EP2195309A4 (fr) 2007-10-08 2013-04-24 Hetero Drugs Ltd Polymorphes de sels de l'ésoméprazole
WO2009049160A1 (fr) 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Procédés de traitement de troubles gastro-intestinaux indépendants de la prise alimentaire
FR2925899B1 (fr) * 2007-12-27 2012-12-21 Sidem Pharma Sa Procede de preparation enantioselective de sulfoxydes.
CN101492459B (zh) * 2008-01-25 2011-04-27 山东轩竹医药科技有限公司 含烷氧乙酰基二氢异噁唑并吡啶化合物
CN101497603B (zh) * 2008-01-30 2012-11-07 山东轩竹医药科技有限公司 含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
EA017064B1 (ru) 2008-03-10 2012-09-28 Такеда Фармасьютикал Компани Лимитед Кристаллическое производное бензимидазола
WO2009117489A1 (fr) * 2008-03-18 2009-09-24 Dr. Reddy's Laboratories Ltd. Procédé de préparation du dexlansoprazole et autres formes polymorphes
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
WO2009145368A1 (fr) * 2008-05-27 2009-12-03 Sk Chemicals Co., Ltd. Procédé amélioré de préparation de (s)-oméprazole à partir d'un racémate d'oméprazole à l’aide d'un agent de résolution optique
EP2143722A1 (fr) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Procédé de préparation de sodium ésoméprazole de haute pureté chimique et nouvelles formes de sodium ésoméprazole
WO2010039885A2 (fr) * 2008-09-30 2010-04-08 Teva Pharmaceutical Industries Ltd. Formes cristallines du dexlansoprazole
EP2264024A1 (fr) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Procédé de préparation d'inhibiteurs de la pompe à protons énantiomériquement enrichis
IT1391776B1 (it) 2008-11-18 2012-01-27 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo
CZ200990A3 (cs) * 2009-02-16 2010-08-25 Zentiva, K.S. Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
WO2010097583A1 (fr) 2009-02-24 2010-09-02 Cipla Limited Polymorphe de l'ésoméprazole de potassium et sa préparation
CZ2009172A3 (cs) * 2009-03-17 2010-09-29 Zentiva, K.S. Zpusob výroby (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolu
WO2010150276A2 (fr) * 2009-06-02 2010-12-29 Sun Pharmaceutical Industries Limited Procédé d'élaboration de composés sulfoxyde
IT1395118B1 (it) 2009-07-29 2012-09-05 Dipharma Francis Srl Procedimento per la preparazione di dexlansoprazolo cristallino
WO2011058569A1 (fr) 2009-11-12 2011-05-19 Hetero Research Foundation Procédé de dédoublement de l'oméprazole
WO2011092665A1 (fr) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited Procédé pour la préparation de formes cristallines de dexlansoprazole
WO2011161421A1 (fr) 2010-06-24 2011-12-29 Cipla Limited Sels et polymorphes de la dexrabéprazole
CN101914090B (zh) * 2010-08-13 2013-03-20 埃斯特维华义制药有限公司 左旋奥美拉唑的制备方法
CN102558150B (zh) * 2010-12-31 2014-03-12 正大天晴药业集团股份有限公司 取代亚砜化合物的合成方法
CN102321071B (zh) * 2011-07-20 2013-01-23 江苏奥赛康药业股份有限公司 一种高纯度埃索美拉唑钠的工业化生产方法
CN102977076A (zh) * 2011-09-02 2013-03-20 扬子江药业集团上海海尼药业有限公司 一种右兰索拉唑的制备方法
CN102329302A (zh) * 2011-10-22 2012-01-25 刘强 一种埃索美拉唑及其盐的制备方法
CN102408412A (zh) * 2011-10-25 2012-04-11 广东华南药业集团有限公司 高对映体选择性制备（s）- 奥美拉唑的方法
CN102432412A (zh) * 2011-10-28 2012-05-02 成都欣捷高新技术开发有限公司 一种手性亚砜类质子泵抑制剂或其可药用盐的制备方法
KR101300950B1 (ko) * 2011-10-31 2013-08-27 르노삼성자동차 주식회사 전기자동차의 공기 흡입 장치
WO2013140120A1 (fr) 2012-03-22 2013-09-26 Cipla Limited Formes solvatées de glycérol de (r)-2-[[[3-methyl-4(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphinyl]-lh-benzimidazole
CN102633776B (zh) * 2012-03-28 2014-06-18 中山市仁合药业有限公司 一种埃索美拉唑及其钠盐的制备方法
CN102659763B (zh) * 2012-04-27 2014-01-22 南京优科生物医药研究有限公司 一种右旋兰索拉唑合成与纯化的方法
CN103044402B (zh) * 2012-12-31 2015-01-14 康普药业股份有限公司 埃索美拉唑钠合成生产方法
CN103113351B (zh) * 2013-03-08 2015-01-21 苏州特瑞药业有限公司 一种光学纯手性亚砜类化合物的制备方法
CN104177336A (zh) * 2013-05-28 2014-12-03 上海汇伦生命科技有限公司 一种对映选择性合成右兰索拉唑的方法
US10130618B2 (en) 2014-04-11 2018-11-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of dabigatran and proton pump inhibitors
WO2015155307A1 (fr) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Combinaisons pharmaceutiques de rivaroxaban et d'inhibiteurs de pompe à protons
EP2980086B1 (fr) 2014-07-29 2016-06-15 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé efficace pour la préparation d'ésoméprazole (S)-binol complexe
CN107428726B (zh) * 2014-12-26 2021-03-16 国立大学法人东京大学 光学活性的质子泵抑制剂化合物的制备方法
CN104610226A (zh) * 2014-12-31 2015-05-13 广东东阳光药业有限公司 一种右兰索拉唑的不对称氧化方法
ES2615637T3 (es) 2015-03-06 2017-06-07 F.I.S.- Fabbrica Italiana Sintetici S.P.A. Procedimiento mejorado para la purificación óptica del esomeprazol
CN105218391B (zh) * 2015-07-09 2017-11-21 天津青松华药医药有限公司 L‑酒石酸单酯单酰胺类化合物
CN105218392B (zh) * 2015-07-09 2017-11-21 天津青松华药医药有限公司 D‑酒石酸单酯单酰胺类化合物
CN105968097B (zh) * 2016-05-17 2019-05-03 杭州华东医药集团新药研究院有限公司 左旋泮托拉唑的工业化生产方法
CN106083818A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种高纯度埃索美拉唑钠的制备方法
CN106366070B (zh) * 2016-08-10 2019-06-11 上海万巷制药有限公司 一种高纯度埃索美拉唑钠的制备方法
EP3512840B1 (fr) * 2016-09-14 2024-03-06 Yufeng Jane Tseng Nouveaux dérivés de benzimidazole substitués utilisés en tant qu'inhibiteurs de la d-amino-acide oxydase (daao)
CN106632249A (zh) * 2016-09-30 2017-05-10 青岛云天生物技术有限公司 一种制备(s)‑泮托拉唑钠的方法
CN106632248A (zh) * 2016-09-30 2017-05-10 青岛云天生物技术有限公司 一种左旋泮托拉唑钠的制备工艺
CN106866630B (zh) * 2017-04-01 2018-08-07 上海华源医药科技发展有限公司 一种右兰索拉唑的制备方法
CN110746428A (zh) * 2019-10-29 2020-02-04 株洲千金药业股份有限公司 一种r型手性亚砜类化合物的制备方法
CN110698482A (zh) * 2019-10-29 2020-01-17 株洲千金药业股份有限公司 一种s型手性亚砜类化合物的制备方法
CN113845510B (zh) * 2020-06-27 2025-02-18 鲁南制药集团股份有限公司 一种埃索美拉唑的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
IL103185A0 (en) * 1991-09-16 1993-02-21 Catalytica Inc Process and catalyst for producing bromine
CA2136993A1 (fr) * 1992-06-01 1993-12-09 Takeshi Kawakita Compose de la pyridine et son utilisation pharmaceutique
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution

Also Published As

Publication number Publication date
IL114477A0 (en) 1995-11-27
SA95160294B1 (ar) 2006-07-31
NO312101B1 (no) 2002-03-18
ATE242233T1 (de) 2003-06-15
KR970704731A (ko) 1997-09-06
CA2193994C (fr) 2005-05-03
JPH10504290A (ja) 1998-04-28
EP0773940B2 (fr) 2010-11-17
UA47409C2 (uk) 2002-07-15
SI0773940T1 (en) 2004-02-29
IS1772B (is) 2001-06-01
EP0773940A1 (fr) 1997-05-21
AU688074B2 (en) 1998-03-05
FI117672B (fi) 2007-01-15
AR003443A1 (es) 1998-08-05
SK284059B6 (sk) 2004-09-08
CA2193994A1 (fr) 1996-02-01
WO1996002535A1 (fr) 1996-02-01
TR199500861A2 (tr) 1996-06-21
MX9700358A (es) 1997-04-30
SK4897A3 (en) 1997-08-06
CZ297987B6 (cs) 2007-05-16
SE504459C2 (sv) 1997-02-17
DE69530987D1 (de) 2003-07-10
CZ6497A3 (en) 1997-06-11
CN1157614A (zh) 1997-08-20
NO970153L (no) 1997-01-14
FI970102L (fi) 1997-01-10
DZ1911A1 (fr) 2002-02-17
EG24534A (en) 2009-08-30
DK0773940T3 (da) 2003-09-15
DE69530987T2 (de) 2004-05-19
JP3795917B2 (ja) 2006-07-12
DK0773940T4 (da) 2011-02-07
IS4406A (is) 1996-12-27
SI0773940T2 (sl) 2011-02-28
EP0773940B1 (fr) 2003-06-04
KR100356252B1 (ko) 2002-11-18
FI117830B (fi) 2007-03-15
YU49475B (sh) 2006-05-25
BR9508292A (pt) 1997-12-23
YU47695A (sh) 1998-07-10
PL318165A1 (en) 1997-05-26
HK1008331A1 (en) 1999-05-07
ZA955724B (en) 1996-01-15
FI970102A0 (fi) 1997-01-10
SE9402510D0 (sv) 1994-07-15
NZ289959A (en) 1998-01-26
US5948789A (en) 1999-09-07
ES2199998T5 (es) 2011-03-16
HUT76642A (en) 1997-10-28
PT773940E (pt) 2003-10-31
SE9402510L (sv) 1996-01-16
IL114477A (en) 2001-07-24
MY113180A (en) 2001-12-31
AU2994895A (en) 1996-02-16
DE69530987T3 (de) 2011-07-07
HRP950401B1 (en) 2004-04-30
RU2157806C2 (ru) 2000-10-20
TW372971B (en) 1999-11-01
PL186342B1 (pl) 2003-12-31
HRP950401A2 (en) 1997-10-31
TNSN95081A1 (fr) 1996-02-06
EE03354B1 (et) 2001-02-15
CN1070489C (zh) 2001-09-05
NO970153D0 (no) 1997-01-14
HU226361B1 (en) 2008-09-29
WO1996002535A8 (fr) 1999-12-23
ES2199998T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
MA23611A1 (fr) Procede pour la synthese de sulfoxydes substitues
MA22922A1 (fr) Procede pour la preparation de nouveaux composes .
FR2645533B1 (fr) Procede de synthese de sulfonylimidures
MA23270A1 (fr) Procede pour la preparation de nouveaux composes.
EP0846303A4 (fr) Procede ameliore pour la production de prototypes
MA23792A1 (fr) Procede pour la preparation de nouveaux composes
MA24011A1 (fr) Procede pour la preparation de nouveaux composes
MA24055A1 (fr) Procede pour la preparation de nouveaux imidazoles cycloalkyles substitues
MA24426A1 (fr) Procede pour la preparation de nouveaux composes
MA23802A1 (fr) Procede pour la preparation de nouveaux composes
FR2701707B1 (fr) Procede pour la purification de lactide.
FR2740132B1 (fr) Procede pour la preparation de 1,1,1,3,3-pentafluoropropane
MA24427A1 (fr) Procede pour la preparation de nouveaux composes
MA22955A1 (fr) Procede pour la preparation de nouveaux composes .
MA22860A1 (fr) Procede pour la preparation de nouveaux composes.
MA23134A1 (fr) Procede pour la preparation d'aryl-piperidine carbinols .
DZ1946A1 (fr) Procédé pour la préparation de supports.
MA21984A1 (fr) Procede pour la preparation de derives de quilinone .
MA22848A1 (fr) Procede enzymatique pour la preparation des aryl-piperidines
MA23036A1 (fr) Procede pour la preparation de composes.
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
FR2550538B1 (fr) Procede pour la synthese de l'aspartam
EP0763596A4 (fr) Procede pour la production de thrombine
MA24245A1 (fr) Procede pour la preparation de nouveaux composes sulfonylures
MA22927A1 (fr) Procede pour la preparation de nouveaux composes.